{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:38:37Z","timestamp":1788629917922,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Factor XIa (FXIa) is a serine protease that catalyzes the activation of Factor IX (FIX) in the blood coagulation cascade. FXIa and its precursor FXI are emergent therapeutic targets for the development of safer anticoagulant agents. Here, we sought a novel DNA-based agent to inhibit FXIa. Towards this goal, an 80 base, single-stranded DNA aptamer library (containing a 40 base randomized core) was screened for FXIa-binding candidates, using ten rounds of positive and negative selection. After selection, 6 of 89 different sequences inhibited FXIa-mediated chromogenic substrate S2366 cleavage. The most active anti-FXIa aptamer had a hypervariable central sequence 5\u2032-AACCTATCGGACTATTGTTAGTGATTTTTATAGTGT-3\u2032 and was designated Factor ELeven Inhibitory APtamer (FELIAP). FELIAP, but not a scrambled aptamer control (SCRAPT), competitively inhibited FXIa-catalyzed S2366 cleavage, FIX activation, and complex formation with antithrombin. No effect of FELIAP on FXI activation was observed. FELIAP inhibited plasma clotting and thrombin generation assays to a significantly greater extent than SCRAPT. Immobilized FELIAP bound FXIa with strong affinity and an equilibrium binding constant (K<jats:sub>D<\/jats:sub>) in the low nanomolar range determined using surface plasmon resonance. FELIAP is the first FXIa-inhibitory aptamer to be described and constitutes a lead compound to develop related aptamers for <jats:italic>in vivo<\/jats:italic> use.<\/jats:p>","DOI":"10.1038\/s41598-017-02055-x","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T11:42:10Z","timestamp":1494589330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa"],"prefix":"10.1038","volume":"7","author":[{"given":"David A.","family":"Donkor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise J.","family":"Eltringham-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-8189","authenticated-orcid":false,"given":"William P.","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/0192623310389474","volume":"39","author":"AJ Gale","year":"2011","unstructured":"Gale, A. J. Continuing education course #2: current understanding of hemostasis. Toxicol Pathol \n                           39, 273\u2013280, doi:10.1177\/0192623310389474 (2011).","journal-title":"Toxicol Pathol"},{"key":"2055_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJMra0801082","volume":"359","author":"B Furie","year":"2008","unstructured":"Furie, B. & Furie, B. C. Mechanisms of thrombus formation. N Engl J Med \n                           359, 938\u2013949, doi:10.1056\/NEJMra0801082 (2008).","journal-title":"N Engl J Med"},{"key":"2055_CR3","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI60229","volume":"122","author":"N Mackman","year":"2012","unstructured":"Mackman, N. New insights into the mechanisms of venous thrombosis. J Clin Invest \n                           122, 2331\u20132336, doi:10.1172\/JCI60229 (2012).","journal-title":"J Clin Invest"},{"key":"2055_CR4","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet \n                           380, 2095\u20132128, doi:10.1016\/S0140-6736(12)61728-0 (2012).","journal-title":"Lancet"},{"key":"2055_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1056\/NEJM199106273242606","volume":"324","author":"J Hirsh","year":"1991","unstructured":"Hirsh, J. Oral anticoagulant drugs. N Engl J Med \n                           324, 1865\u20131875, doi:10.1056\/NEJM199106273242606 (1991).","journal-title":"N Engl J Med"},{"key":"2055_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/ATVBAHA.115.303397","volume":"35","author":"CH Yeh","year":"2015","unstructured":"Yeh, C. H., Hogg, K. & Weitz, J. I. Overview of the new oral anticoagulants: opportunities and challenges. Arterioscler Thromb Vasc Biol \n                           35, 1056\u20131065, doi:10.1161\/ATVBAHA.115.303397 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2055_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/CIRCULATIONAHA.116.021831","volume":"134","author":"CT Ruff","year":"2016","unstructured":"Ruff, C. T., Giugliano, R. P. & Antman, E. M. Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents. Circulation \n                           134, 248\u2013261, doi:10.1161\/CIRCULATIONAHA.116.021831 (2016).","journal-title":"Circulation"},{"key":"2055_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOH.0b013e3283497e61","volume":"18","author":"F Muller","year":"2011","unstructured":"Muller, F., Gailani, D. & Renne, T. Factor XI and XII as antithrombotic targets. Curr Opin Hematol \n                           18, 349\u2013355, doi:10.1097\/MOH.0b013e3283497e61 (2011).","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 2","key":"2055_CR9","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0049-3848(16)30363-2","volume":"141","author":"JI Weitz","year":"2016","unstructured":"Weitz, J. I. Factor XI and factor XII as targets for new anticoagulants. Thromb Res \n                           141(Suppl 2), S40\u201345, doi:10.1016\/S0049-3848(16)30363-2 (2016).","journal-title":"Thromb Res"},{"key":"2055_CR10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","volume":"115","author":"J Emsley","year":"2010","unstructured":"Emsley, J., McEwan, P. A. & Gailani, D. Structure and function of factor XI. Blood \n                           115, 2569\u20132577, doi:10.1182\/blood-2009-09-199182 (2010).","journal-title":"Blood"},{"key":"2055_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1056\/NEJM200003093421004","volume":"342","author":"JC Meijers","year":"2000","unstructured":"Meijers, J. C., Tekelenburg, W. L., Bouma, B. N., Bertina, R. M. & Rosendaal, F. R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med \n                           342, 696\u2013701, doi:10.1056\/NEJM200003093421004 (2000).","journal-title":"N Engl J Med"},{"key":"2055_CR12","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","volume":"114","author":"M Cushman","year":"2009","unstructured":"Cushman, M., O\u2019Meara, E. S., Folsom, A. R. & Heckbert, S. R. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood \n                           114, 2878\u20132883, doi:10.1182\/blood-2009-05-219915 (2009).","journal-title":"Blood"},{"issue":"Suppl 1","key":"2055_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1538-7836.2009.03393.x","volume":"7","author":"T Renne","year":"2009","unstructured":"Renne, T. et al. Factor XI deficiency in animal models. J Thromb Haemost \n                           7(Suppl 1), 79\u201383, doi:10.1111\/jth.2009.7.issue-s1 (2009).","journal-title":"J Thromb Haemost"},{"key":"2055_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renne","year":"2005","unstructured":"Renne, T. et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med \n                           202, 271\u2013281, doi:10.1084\/jem.20050664 (2005).","journal-title":"J Exp Med"},{"key":"2055_CR15","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","volume":"123","author":"A Matafonov","year":"2014","unstructured":"Matafonov, A. et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood \n                           123, 1739\u20131746, doi:10.1182\/blood-2013-04-499111 (2014).","journal-title":"Blood"},{"key":"2055_CR16","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","volume":"116","author":"Q Cheng","year":"2010","unstructured":"Cheng, Q. et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood \n                           116, 3981\u20133989, doi:10.1182\/blood-2010-02-270918 (2010).","journal-title":"Blood"},{"issue":"Suppl 1","key":"2055_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","volume":"7","author":"U Seligsohn","year":"2009","unstructured":"Seligsohn, U. Factor XI deficiency in humans. J Thromb Haemost \n                           7(Suppl 1), 84\u201387, doi:10.1111\/jth.2009.7.issue-s1 (2009).","journal-title":"J Thromb Haemost"},{"key":"2055_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1405760","volume":"372","author":"HR Buller","year":"2015","unstructured":"Buller, H. R. et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. N Engl J Med \n                           372, 232\u2013240, doi:10.1056\/NEJMoa1405760 (2015).","journal-title":"N Engl J Med"},{"key":"2055_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C Tuerk","year":"1990","unstructured":"Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science \n                           249, 505\u2013510, doi:10.1126\/science.2200121 (1990).","journal-title":"Science"},{"key":"2055_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/bit.25581","volume":"112","author":"E Ouellet","year":"2015","unstructured":"Ouellet, E., Foley, J. H., Conway, E. M. & Haynes, C. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform. Biotechnol Bioeng \n                           112, 1506\u20131522, doi:10.1002\/bit.v112.8 (2015).","journal-title":"Biotechnol Bioeng"},{"key":"2055_CR21","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1074\/jbc.M109.049833","volume":"285","author":"SK Buddai","year":"2010","unstructured":"Buddai, S. K. et al. An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase. J Biol Chem \n                           285, 5212\u20135223, doi:10.1074\/jbc.M109.049833 (2010).","journal-title":"J Biol Chem"},{"key":"2055_CR22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/s-0037-1614126","volume":"84","author":"CP Rusconi","year":"2000","unstructured":"Rusconi, C. P., Yeh, A., Lyerly, H. K., Lawson, J. H. & Sullenger, B. A. Blocking the initiation of coagulation by RNA aptamers to factor VIIa. Thromb Haemost \n                           84, 841\u2013848 (2000).","journal-title":"Thromb Haemost"},{"key":"2055_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1538-7836.2012.04679.x","volume":"10","author":"KM Bompiani","year":"2012","unstructured":"Bompiani, K. M., Monroe, D. M., Church, F. C. & Sullenger, B. A. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity. J Thromb Haemost \n                           10, 870\u2013880, doi:10.1111\/jth.2012.10.issue-5 (2012).","journal-title":"J Thromb Haemost"},{"key":"2055_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/jth.12302","volume":"11","author":"RS Woodruff","year":"2013","unstructured":"Woodruff, R. S. et al. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer. J Thromb Haemost \n                           11, 1364\u20131373, doi:10.1111\/jth.12302 (2013).","journal-title":"J Thromb Haemost"},{"key":"2055_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/355564a0","volume":"355","author":"LC Bock","year":"1992","unstructured":"Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. & Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature \n                           355, 564\u2013566, doi:10.1038\/355564a0 (1992).","journal-title":"Nature"},{"key":"2055_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nbt1023","volume":"22","author":"CP Rusconi","year":"2004","unstructured":"Rusconi, C. P. et al. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol \n                           22, 1423\u20131428, doi:10.1038\/nbt1023 (2004).","journal-title":"Nat Biotechnol"},{"key":"2055_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1538-7836.2012.04742.x","volume":"10","author":"JP Vavalle","year":"2012","unstructured":"Vavalle, J. P. et al. A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent. J Thromb Haemost \n                           10, 1303\u20131311, doi:10.1111\/j.1538-7836.2012.04742.x (2012).","journal-title":"J Thromb Haemost"},{"key":"2055_CR28","doi-asserted-by":"publisher","first-page":"36165","DOI":"10.1074\/jbc.M504990200","volume":"280","author":"D Navaneetham","year":"2005","unstructured":"Navaneetham, D. et al. Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2. J Biol Chem \n                           280, 36165\u201336175, doi:10.1074\/jbc.M504990200 (2005).","journal-title":"J Biol Chem"},{"key":"2055_CR29","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1093\/nar\/gkg595","volume":"31","author":"M Zuker","year":"2003","unstructured":"Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res \n                           31, 3406\u20133415, doi:10.1093\/nar\/gkg595 (2003).","journal-title":"Nucleic Acids Res"},{"key":"2055_CR30","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1021\/bi00719a006","volume":"13","author":"K Fujikawa","year":"1974","unstructured":"Fujikawa, K., Legaz, M. E., Kato, H. & Davie, E. W. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry \n                           13, 4508\u20134516, doi:10.1021\/bi00719a006 (1974).","journal-title":"Biochemistry"},{"key":"2055_CR31","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1021\/bi962274y","volume":"36","author":"AS Wolberg","year":"1997","unstructured":"Wolberg, A. S., Morris, D. P. & Stafford, D. W. Factor IX activation by factor XIa proceeds without release of a free intermediate. Biochemistry \n                           36, 4074\u20134079, doi:10.1021\/bi962274y (1997).","journal-title":"Biochemistry"},{"key":"2055_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1365-2141.2004.05106.x","volume":"126","author":"WP Sheffield","year":"2004","unstructured":"Sheffield, W. P. et al. Effects of genetic fusion of factor IX to albumin on in vivo clearance in mice and rabbits. Br J Haematol \n                           126, 565\u2013573, doi:10.1111\/j.1365-2141.2004.05106.x (2004).","journal-title":"Br J Haematol"},{"key":"2055_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1042\/bj2560815","volume":"256","author":"H Soons","year":"1988","unstructured":"Soons, H., Tans, G. & Hemker, H. C. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type. Biochem J \n                           256, 815\u2013820, doi:10.1042\/bj2560815 (1988).","journal-title":"Biochem J"},{"key":"2055_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1365-2141.1996.319855.x","volume":"92","author":"WA Wuillemin","year":"1996","unstructured":"Wuillemin, W. A., Mertens, K., ten Cate, H. & Hack, C. E. Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin. Br J Haematol \n                           92, 466\u2013472, doi:10.1046\/j.1365-2141.1996.319855.x (1996).","journal-title":"Br J Haematol"},{"key":"2055_CR35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","volume":"96","author":"HC Hemker","year":"2006","unstructured":"Hemker, H. C., Al Dieri, R., De Smedt, E. & Beguin, S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost \n                           96, 553\u2013561 (2006).","journal-title":"Thromb Haemost"},{"key":"2055_CR36","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1021\/bi9925468","volume":"39","author":"KO Badellino","year":"2000","unstructured":"Badellino, K. O. & Walsh, P. N. Protease nexin II interactions with coagulation factor XIa are contained within the Kunitz protease inhibitor domain of protease nexin II and the factor XIa catalytic domain. Biochemistry \n                           39, 4769\u20134777, doi:10.1021\/bi9925468 (2000).","journal-title":"Biochemistry"},{"key":"2055_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ymeth.2016.04.020","volume":"106","author":"YX Wu","year":"2016","unstructured":"Wu, Y. X. & Kwon, Y. J. Aptamers: The \u201cevolution\u201d of SELEX. Methods \n                           106, 21\u201328, doi:10.1016\/j.ymeth.2016.04.020 (2016).","journal-title":"Methods"},{"key":"2055_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature00963","volume":"419","author":"CP Rusconi","year":"2002","unstructured":"Rusconi, C. P. et al. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature \n                           419, 90\u201394, doi:10.1038\/nature00963 (2002).","journal-title":"Nature"},{"key":"2055_CR39","doi-asserted-by":"publisher","first-page":"12779","DOI":"10.1074\/jbc.M111.300772","volume":"287","author":"B Sullenger","year":"2012","unstructured":"Sullenger, B., Woodruff, R. & Monroe, D. M. Potent anticoagulant aptamer directed against factor IXa blocks macromolecular substrate interaction. J Biol Chem \n                           287, 12779\u201312786, doi:10.1074\/jbc.M111.300772 (2012).","journal-title":"J Biol Chem"},{"key":"2055_CR40","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1074\/jbc.A114.607359","volume":"290","author":"CA Kretz","year":"2015","unstructured":"Kretz, C. A., Stafford, A. R., Fredenburgh, J. C. & Weitz, J. I. HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase. J Biol Chem \n                           290, 4813\u20134813, doi:10.1074\/jbc.A114.607359 (2015).","journal-title":"J Biol Chem"},{"key":"2055_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1006\/jmbi.1997.1275","volume":"272","author":"DM Tasset","year":"1997","unstructured":"Tasset, D. M., Kubik, M. F. & Steiner, W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol \n                           272, 688\u2013698, doi:10.1006\/jmbi.1997.1275 (1997).","journal-title":"J Mol Biol"},{"key":"2055_CR42","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1021\/jm5002698","volume":"57","author":"MD Argade","year":"2014","unstructured":"Argade, M. D., Mehta, A. Y., Sarkar, A. & Desai, U. R. Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. J Med Chem \n                           57, 3559\u20133569, doi:10.1021\/jm5002698 (2014).","journal-title":"J Med Chem"},{"key":"2055_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1182\/blood-2012-03-419523","volume":"120","author":"W Wu","year":"2012","unstructured":"Wu, W. et al. The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis. Blood \n                           120, 671\u2013677, doi:10.1182\/blood-2012-03-419523 (2012).","journal-title":"Blood"},{"key":"2055_CR44","doi-asserted-by":"publisher","first-page":"11405","DOI":"10.1038\/srep11405","volume":"5","author":"R Gysbers","year":"2015","unstructured":"Gysbers, R., Tram, K., Gu, J. & Li, Y. Evolution of an Enzyme from a Noncatalytic Nucleic Acid Sequence. Sci Rep \n                           5, 11405, doi:10.1038\/srep11405 (2015).","journal-title":"Sci Rep"},{"key":"2055_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00001721-200109000-00003","volume":"12","author":"WP Sheffield","year":"2001","unstructured":"Sheffield, W. P., Smith, I. J., Syed, S. & Bhakta, V. Prolonged in vivo anticoagulant activity of a hirudin-albumin fusion protein secreted from Pichia pastoris. Blood Coagul Fibrinolysis \n                           12, 433\u2013443, doi:10.1097\/00001721-200109000-00003 (2001).","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02055-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:25:59Z","timestamp":1671769559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02055-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]},"assertion":[{"value":"13 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2102"}}